Violina Frenkel
Neuromuscular Medicine · Summit, NJNPI 1407017874
Payments from drug & device makers
Across 1,488 payments — averaging $390.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$411K
- Axsome Therapeutics, Inc.$93K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$37K
- Otsuka America Pharmaceutical, Inc.$15K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- Corium, LLC$6K
- plus $11K from 31 others
What the payments were for
- Consulting fees$37,8737%
- Speaking & faculty fees$448,93777%
- Travel & lodging$71,33612%
- Food & beverage$23,0534%
- Education$1530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromuscular medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 14 | $20,743 |
| Adzenys Xr-OdtAmphetamine | 21 | $10,015 |
| Lurasidone Hcl | 18 | $8,302 |
| Paliperidone ErPaliperidone | 11 | $4,943 |
| CymbaltaDuloxetine Hcl | 12 | $3,244 |
| Vilazodone Hcl | 19 | $1,585 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $965 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 68 | $954 |
| Trazodone Hcl | 45 | $585 |
| Lorazepam | 61 | $542 |
| Fluoxetine Hcl | 32 | $450 |
| Duloxetine Hcl | 26 | $449 |
| Alprazolam | 103 | $404 |
| Bupropion Hcl | 11 | $328 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 30 | $308 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $36,872 | $20,74314 claims |
| Neos Therapeutics, LPAdzenys Xr-Odt | $855 | $10,01521 claims |
| Lilly USA, LLCCymbalta | $20 | $3,24412 claims |
| Almatica Pharma LLCSertraline Hcl | $259 | $9218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromuscular medicine providers in New Jerseyon file to place this against a meaningful peer group, so we don't.
Other neuromuscular medicine in Summit
- Jillian AldersonSummit$943
- Beth SteinPaterson$87K
- James HianaEnglewood$894
- Leila MaybodiNewark$27
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.